 Estradiol
"Estradiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
| Descriptor ID |
D004958
|
| MeSH Number(s) |
D04.210.500.365.415.248 D06.472.334.851.437.500
|
| Concept/Terms |
Estradiol- Estradiol
- Estradiol-17 beta
- Estradiol 17 beta
- Estradiol Anhydrous
- Oestradiol
- Estradiol-17beta
- Estradiol 17beta
- 17 beta-Estradiol
- 17 beta Estradiol
- 17 beta-Oestradiol
- 17 beta Oestradiol
|
Below are MeSH descriptors whose meaning is more general than "Estradiol".
Below are MeSH descriptors whose meaning is more specific than "Estradiol".
This graph shows the total number of publications written about "Estradiol" by people in this website by year, and whether "Estradiol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 | | 1996 | 3 | 2 | 5 | | 1997 | 2 | 3 | 5 | | 1998 | 2 | 4 | 6 | | 1999 | 0 | 2 | 2 | | 2000 | 4 | 4 | 8 | | 2001 | 4 | 4 | 8 | | 2002 | 6 | 4 | 10 | | 2003 | 9 | 4 | 13 | | 2004 | 2 | 2 | 4 | | 2005 | 6 | 5 | 11 | | 2006 | 6 | 7 | 13 | | 2007 | 9 | 8 | 17 | | 2008 | 8 | 11 | 19 | | 2009 | 4 | 8 | 12 | | 2010 | 10 | 6 | 16 | | 2011 | 5 | 8 | 13 | | 2012 | 6 | 9 | 15 | | 2013 | 8 | 7 | 15 | | 2014 | 5 | 7 | 12 | | 2015 | 8 | 8 | 16 | | 2016 | 7 | 4 | 11 | | 2017 | 6 | 8 | 14 | | 2018 | 6 | 7 | 13 | | 2019 | 6 | 5 | 11 | | 2020 | 6 | 8 | 14 | | 2021 | 5 | 5 | 10 | | 2022 | 0 | 7 | 7 | | 2023 | 1 | 9 | 10 | | 2024 | 5 | 2 | 7 | | 2025 | 7 | 4 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Estradiol" by people in Profiles.
-
Misakian AL, Kelley CE, Sullivan EA, Chang JJ, Singh G, Kokosa S, Avila J, Cooper H, Liang JW, Botzheim B, Quint M, Jeevananthan A, Chi E, Harmer M, Hiatt L, Kowalewski M, Steinberg B, Tausinga T, Tanner H, Ho TF, Mark B, Zenger B, Hu S, Gebregzabheir A, Penny JM, Loeb DF, Strickland T, Iwamoto SJ, Rothman MS, Hamnvik OR, Ariel D. Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States. J Clin Endocrinol Metab. 2025 Aug 07; 110(9):e2898-e2907.
-
Richey RE, Miner JA, Miner JC, Brunt VE, Kaplan PF, Halliwill JR, Minson CT. Exogenous estradiol increases cardiovagal baroreflex sensitivity during a hypertensive stimulus in premenopausal young women. Am J Physiol Heart Circ Physiol. 2025 Aug 01; 329(2):H439-H449.
-
Ogren AN, Zimmerman NJ, Stark S, McClellan M, Gonzalez SJ, Hartweck LM, Prins KW, Gardner MK. Estradiol pauses microtubule growth without increased incidence of catastrophe events. Commun Biol. 2025 Jun 18; 8(1):938.
-
Hiransuthikul A, Thammajaruk N, Kerr S, Janamnuaysook R, Nonenoy S, Hongchookiat P, Trichavaroj R, Tawon Y, Boonruang J, Teeratakulpisarn N, Cressey TR, Anderson PL, Phanuphak N. No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study. J Int AIDS Soc. 2025 May; 28(5):e26502.
-
Han AL, Vinod Paul K, Rao S, Brechbuhl HM, Sartorius CA, Ramachandran S, Kabos P. Estradiol (E2) concentration shapes the chromatin binding landscape of estrogen receptor alpha. J Biol Chem. 2025 Jul; 301(7):108499.
-
Spritzer MD, Roy EA, Calhoun KMK, Schneider-Lynch ZE, Panella L, Michaelcheck C, Qian A, Kelly ED, Barr H, Hall E, Cunningham B, Nguyen HHM, Xu D, Barker JM, Galea LAM. Effects of Testosterone and Its Major Metabolites upon Different Stages of Neuron Survival in the Dentate Gyrus of Male Rats. Biomolecules. 2025 Apr 07; 15(4).
-
van Eeghen SA, Pyle L, Narongkiatikhun P, Choi YJ, Obeid W, Parikh CR, Vosters TG, van Valkengoed IG, Krebber MM, Touw DJ, den Heijer M, Bjornstad P, van Raalte DH, Nokoff NJ. Unveiling mechanisms underlying kidney function changes during sex hormone therapy. J Clin Invest. 2025 May 01; 135(9).
-
Santoro N, Neal-Perry G, Stute P, Blogg M, Mancuso S, Morga A, Ottery FD, Siddiqui E. Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy. Curr Med Res Opin. 2025 Feb; 41(2):375-384.
-
Scholl JL, Rogers JT, Feng N, Forster GL, Watt MJ, Yaeger JDW, Buchanan MW, Lowry CA, Renner KJ. Corticosterone rapidly modulates dorsomedial hypothalamus serotonin and behavior in an estrogen- and progesterone-dependent manner in adult female rats: potential role of organic cation transporter 3 (OCT3). Stress. 2025 Dec; 28(1):2457765.
-
Levy MV, Fandl HK, Hijmans JG, Stockelman KA, Ruzzene ST, Reiakvam WR, Goldthwaite ZA, Greiner JJ, DeSouza CA, Garcia VP. Effect of 17ß-Estradiol on Endothelial Cell Expression of Inflammation- Related MicroRNA. Microrna. 2025; 14(1):3-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|